MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108. A total of 91 filers reported holding MAGENTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $220,000 | +15.8% | 28,000 | 0.0% | 0.01% | +14.3% |
| Q3 2020 | $190,000 | -9.5% | 28,000 | 0.0% | 0.01% | -12.5% |
| Q2 2020 | $210,000 | +19.3% | 28,000 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $176,000 | -58.5% | 28,000 | 0.0% | 0.01% | -42.9% |
| Q4 2019 | $424,000 | +47.7% | 28,000 | 0.0% | 0.01% | +40.0% |
| Q3 2019 | $287,000 | -35.1% | 28,000 | -6.7% | 0.01% | -33.3% |
| Q2 2019 | $442,000 | -10.5% | 30,000 | 0.0% | 0.02% | -21.1% |
| Q1 2019 | $494,000 | +188.9% | 30,000 | 0.0% | 0.02% | +137.5% |
| Q4 2018 | $171,000 | -52.5% | 30,000 | 0.0% | 0.01% | -42.9% |
| Q3 2018 | $360,000 | – | 30,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 6,758,204 | $8,110,000 | 5.33% |
| TCG Crossover Management, LLC | 2,124,122 | $2,549,000 | 1.08% |
| Atlas Venture Life Science Advisors, LLC | 3,476,536 | $4,172,000 | 0.70% |
| HELLMAN JORDAN MANAGEMENT CO INC /MA/ | 295,000 | $354,000 | 0.48% |
| Deep Track Capital, LP | 5,359,000 | $6,431,000 | 0.42% |
| GREAT POINT PARTNERS LLC | 1,170,000 | $1,404,000 | 0.34% |
| Casdin Capital, LLC | 2,415,000 | $2,898,000 | 0.24% |
| Alphabet Inc. | 3,339,138 | $4,007,000 | 0.22% |
| HARBOR CAPITAL ADVISORS, INC. | 159,307 | $191,000 | 0.14% |
| Bleichroeder LP | 484,400 | $581,000 | 0.12% |